Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia
JB Christian, B Arondekar, EK Buysman… - The American Journal of …, 2014 - Elsevier
Background Patients with severe hypertriglyceridemia have an increased risk of
cardiovascular disease and pancreatitis. Target triglyceride levels associated with clinical
benefit for patients with severe hypertriglyceridemia are not currently known. This study
evaluates the association between lower follow-up triglyceride levels and incidence of
clinical events for patients with severe hypertriglyceridemia. Methods By using claims data
from 2 large US healthcare databases, we conducted a retrospective cohort study and …
cardiovascular disease and pancreatitis. Target triglyceride levels associated with clinical
benefit for patients with severe hypertriglyceridemia are not currently known. This study
evaluates the association between lower follow-up triglyceride levels and incidence of
clinical events for patients with severe hypertriglyceridemia. Methods By using claims data
from 2 large US healthcare databases, we conducted a retrospective cohort study and …